Nicholas Investment Partners, LP Talis Biomedical Corp Transaction History

Nicholas Investment Partners, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.17 $3.77 Million - $6.1 Million	-989,090 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.02 - $12.46 $494,994 - $1.02 Million	-82,225 Reduced 7.68%	989,090 $6.18 Million
Q2 2021 Aug 10, 2021	SELL	$9.62 - $14.56 $289,427 - $438,052	-30,086 Reduced 2.73%	1,071,315 $11.8 Million
Q1 2021 May 14, 2021	BUY	$11.2 - $27.8 $12.3 Million - $30.6 Million	1,101,401 New	1,101,401 $14.2 Million

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $45.3M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.